BVI Launches PODEYE Hydrophobic Monofocal IOL in Japan
18 April 2024 - 3:00AM
BVI, the most dynamic, diversified company in ophthalmology,
announced today the official launch of the PODEYE hydrophobic
monofocal IOL in Japan following approval by the Japanese
Pharmaceuticals and Medical Devices Agency (PMDA). The achievement
represents another significant step in BVI’s plan to launch its
range of IOLs in Japan over the near-term.
Being unveiled at the Japanese Ophthalmic
Society (JOS) annual meeting in Tokyo, PODEYE is now available for
commercial use and available to surgeons across the country.
“Our commitment to the Japanese ophthalmic
market is a clear priority for BVI. The PODEYE launch continues to
execute on our strategic vision and global expansion. We are set to
equip surgeons with more solutions to enhance patient care.
Anticipate more groundbreaking product launches from us in Japan
and many other major markets globally.” said Shervin Korangy,
President and CEO of BVI.
Stability Made Simple.With a
focus on IOL stability, the now proven double C-loop haptic design,
known as ‘POD’ which is unique only to BVI lenses, was first
introduced to the market with the launch of the PODEYE hydrophobic
IOL in Europe in 2012. BVI has demonstrated the success of its POD
technology with over 10 years of accomplished sales worldwide.
Renowned for its novel, one-of-a-kind (double C-loop) haptic
design, ensuring reliable IOL centration and rotational stability,
the POD platform has gained substantial popularity and serves as
the foundation for all future BVI IOLs.
Focus on SafetyGiven that Japan
is primarily a hydrophobic market, surgeons in Japan, like their
counterparts worldwide, will appreciate the proprietary,
hydrophobic ‘GFY®’ material from which BVI IOLS are made providing
100% glistening-free material.
Moreover, the company has also demonstrated
market-wide expertise in IOL material development. Alongside its
patented GFY material featured exclusively in BVI lenses, BVI also
develops and supplies approximately 20% of IOL material for
competing IOL companies globally from its facility in Florida,
US.
About BVIBVI® is a diversified
global ophthalmic device company with a mission to deliver
high-quality solutions and innovation for advancing eye surgery and
improving the vision of patients. With nine decades of developing
leading products and solutions, BVI partners with ophthalmic
surgeons to improve the vision of millions of patients across the
globe. Our organization supports surgical teams in more than 90
countries worldwide, either directly or through our network of
trusted distributors. Our trusted brands include Beaver® (Knives
and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments),
Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium
IOLs).
For further enquiries or to speak to a BVI
representative, please email Andrew Dawson, Head of BVI Corporate
Communications: adawson@bvimedical.com
1 Market Scope Data